by LAMPIRE and INVITRIA
Serum-Free Cell Culture Can Cost Less: Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost
Click HERE to view the Webinar.
Monoclonal antibodies are a valuable asset in the development of future of medicines, from use as basic research tools to large-scale biotherapeutics. Given the versatility and convenience represented by using hybridomas to produce monoclonal antibodies (MAbs), scientists continue to expand upon the vast potential these proteins represent. However, limitations in hybridoma productivity and costly purification processes associated with contaminating materials found in the culture medium can significantly increase MAb costs.
In this webinar, we will discuss:
• Challenges facing (non-therapeutic) MAb production
• Case Study: Lampire Biological Laboratories' ability to positively impact cost and performance under serum-free conditions
• Elimination of animal-derived components to improve
- purification processes,
- consistency of system performance, and
- regulatory compliance
Join us today for a live one hour event!
Title: Serum-Free Cell Culture Can Cost Less: Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost
Date: Tuesday, May 10, 2011
Time: 11:30 AM - 12:30 PM MDT
After registering you will receive a confirmation email containing information about joining the Webinar.
Required: Windows 7, Vista, XP or 2003 Server
Required: Mac OS X 10.4.11 (Tiger) or newer
Space is limited.
Reserve your Webinar seat now!